Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
Abstract Introduction Therapeutic burden (TB) has been proposed as a potential predictor of treatment outcomes in both dermatological and non-dermatological diseases. This study aims to introduce the concept in the context of alopecia areata (AA) and assess its potential value in supporting therapeu...
Saved in:
| Main Authors: | Daniel Muñoz-Barba, Alberto Soto-Moreno, Sofía Haselgruber-de Francisco, Manuel Sánchez-Díaz, Salvador Arias-Santiago |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-07-01
|
| Series: | Dermatology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s13555-025-01468-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Janus kinase inhibitors for alopecia areata: a review of clinical data
by: Yutong Sun, et al.
Published: (2025-05-01) -
Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib
by: Manuel Darío Franco, et al.
Published: (2024-01-01) -
Modern Management Approaches for Alopecia Areata
by: Eduard T. Ambarchyan, et al.
Published: (2024-12-01) -
Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
by: Sihan Wang, et al.
Published: (2025-01-01) -
Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
by: Julien Seneschal, et al.
Published: (2025-05-01)